Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-20

Clinical Trial Update: Inpatient Penicillin Allergy Delabeling Study [Phase 4]

View source ↗

Summary

Phase 4 inpatient penicillin allergy delabeling study completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Penicillin Allergy, Penicillin Sensitivity | Phase 4 | Status: COMPLETED | Results posted: 2023-07-20